For example, administration of exogenous GM-CSF reduces disease in numerous animal models of autoimmunity including myasthenia gravis, thyroiditis, type 1 diabetes, and graft versus host disease [33–37]. The gene discussed is CSF2; the disease is myasthenia gravis.